Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > No share price change in US past two days
View:
Post by Gooseybear on Jun 26, 2024 10:13am

No share price change in US past two days

Very interesting. Stock trading hasn't been stopped has it?
Comment by Alamir1111 on Jun 26, 2024 11:13am
The bcg strain that ibrx is using is more potent than mercks own.There are already trials going on in europe. keytruda is already facing challenge due to patent expiry now their bcg is getting challenged.. cell-based experiments, the new compound, nicknamed RuBCG, was able to significantly increase the efficacy of BCG in cancer cell kill versus BCG or RuvidarTM alone, when non-light ...more  
Comment by Alamir1111 on Jun 26, 2024 11:23am
What I'm really excited about is the potential that the Serum Institute's next generation recombinant BCG is even more potent, more immunogenic, and even, according to them from the phase two data in Europe, safer than the current BCG. So yes, I think the combination of the synergistic effect of the BCG giving you the CD4, CD8 T cells, and then our Anktiva proliferating that as well as ...more  
Comment by Oilminerdeluxe on Jun 26, 2024 1:27pm
When is the PP supposed to close? Any date given?
Comment by riverrrow on Jun 26, 2024 3:32pm
I heard it was supposed to close June 28.  If they had the 10 mil lined up beforehand that could happen.  My guess is it closes July 5.  GLTA.
Comment by Oilminerdeluxe on Jun 26, 2024 3:46pm
Thank you.
Comment by Legit62 on Jun 26, 2024 5:26pm
Picked up more today at these rediculous low  prices, couldnt help but not buy, sitting pretty at low averaged in price, waiting for show to begin
Comment by 2b7f6fab on Jun 26, 2024 3:02pm
Interesting, does it do anything for brain, lung, breast, colon etc?
Comment by gojotv! on Jun 26, 2024 3:10pm
"the new compound, nicknamed RuBCG, was able to significantly increase the efficacy of BCG in cancer cell kill versus BCG or RuvidarTM alone, when non-light activated." Luckily, Ruvidar, when it IS light-activated, as is the protocol, is so effective that it needs no help from inferior, old medications. Ruvidar is so safe that our Phase 1 study was halted and we could go ...more  
Comment by Gooseybear on Jun 26, 2024 3:19pm
Great advice! Until one of the FDA politicians or their family members or friends dies of blacd cancer or GBM they will do a slow roll. Big pharma wants TLTFF to fail as they are greedy SOBs with the political forces that support them. I've seen this slow roll happen before and the small companies run out of cash and the big boys come in a swoop up their products for little or nothing. As ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250